| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Canada | 3 | |
| #4 | Australia | 1 | |
| #5 | Germany | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Unspecified technologies | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vollmers Heinz | 8 |
| #2 | Mueller-Hermelink Hans-Konrad | 8 |
| #3 | Vollmers Heinz Peter | 4 |
| #4 | Hensel Frank | 3 |
| #5 | Mueller-Hermelink Hans Konrad | 2 |
| #6 | Vollmers Heinz P | 1 |
| #7 | Muller-Hermelink Hans K | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP1742969A2 | Methods of identifying neoplasm-specific antibodies and uses thereof | |
| WO2005047332A1 | Adenocarcinoma specific antibody sam-6, and uses thereof | |
| DE102004015179A1 | Antigen of the PM-2 antibody and its use | |
| AU2003249533A1 | Neoplasm specific antibodies and uses thereof |